Preparation of extracts
Between 10 and 30 mg of tissue were obtained and transferred to a pre-weight Eppendorf tube containing a steel bead. Then, 30 µL (per 10 mg of tissue) of a methanol: water mixture (4:1, containing the negative-mode internal standard heptadecanoic acid 10 µg/mL) was added and the samples were homogenized for 5 min at 25 Hz (10 cycles of 0.5 min) in a TissueLyser (Qiagen, MD, US). Following this, 70 µl of the homogenate was added to an amber glass HPLC vial containing a 300 µl glass insert (Chromacol, UK). To this 200 µl of Methyl tert-butyl ether (MTBE) containing 10 µg/mL of positive-mode internal standard (tripentadecanoin) was added, and the samples were mixed via vortexing at room temperature for 60 min. Then, 30 µl of high purity water was added and samples were centrifuged at 2500g for 20 min at 4 ºC. Another 35 µl of the homogenate from each sample was taken to form the pooled QC samples. Same procedures were followed for QCs extraction. The upper lipid-containing MTBE phase was then injected onto the LC-MS system directly from the vial. Two different ionization modes including positive and negative were performed for each sample. QC sample was running in between every 8 samples.
Chromatographic and mass spectrometry conditions
Chromatographic separation for lipidomics (phase one and two) was achieved using an Agilent Poroshell 120 EC-C8 column (150mm × 2.1mm, 2.7 μm), maintained at 55 °C. A gradient was employed consisting of 10 mM ammonium formate in water (A) and 10mM ammonium formate in methanol (B). The solvent was delivered at a flow rate of 0.5 mL/min.
The gradient consisted of 0 min (75% B), 23 min (96% B), 36 min (96% B), 36.5 min (100% B), and 41.5 min (100% B). The column was re-equilibrated at 75% B for 9 minutes prior to each injection. The mass spectrometer (Xevo-QTOF) was operated in positive and negative ion mode. For positive mode, a capillary voltage of 3.2 kV and a cone voltage of 45 V were used. The desolvation gas flow was 400 L/hour and the source temperature was 120°C. All analyses were acquired using the lock spray to ensure accuracy and reproducibility; leucine enkephalin was used as lock mass (m/z 556.2771 and 278.1141) at a concentration of 200 ng/mL and a flow rate of 10 μL/min. Data were collected in the centroid mode over the mass range m/z 100-1000 with an acquisition time of 0.1 seconds a scan. For negative mode, a capillary voltage of -2.6 kV and a cone voltage of 45 V were used. Desolvation gas flow and source temperature were fixed at 800 L/h and 350 ºC, respectively. A reference solution (leucine enkephalin) was infused at regular intervals, and use to update accurate mass data values. high LysoPC(18:0) 
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